IGF-1 DES (1–3)
Des 1-3 IGF-I / IGF-1 DES
- Peptide length
- 67 amino acids
N-terminally truncated protein
Open the sources to check how the studies were done and what they can support.
An IGF-I form lacking the first three residues, investigated for altered interactions with IGF-binding proteins.
- Family
- Truncated IGF-I
- Research target
- IGF-1 receptor pathway
- Molecular form
- N-terminally truncated protein
What to know about the research
The cited work used cell systems and purified binding proteins. It does not establish a safe or effective human anabolic intervention.
Check the exact compound
The experiment compared des-(1–3)-IGF-I with IGF-I and IGF-II. Keep these materials distinct when reading the results.
What supports this entry?
3 of 3 summary statements linked to checked source passages.
These are selected references, not a complete review of the literature. Source checks were assisted by AI and have not received independent expert review.
Research stage, study quality and regulatory status answer different questions. A study card does not establish treatment benefit or approval.
Check the overview statementSource checked
An IGF-I form lacking the first three residues, investigated for altered interactions with IGF-binding proteins.
Abstract: numbered findings 2–4
- Selected primary-source passages checked with AI assistance. Scope cautions are editorial interpretations; this is not a complete literature review.
Check the evidence limitationSource checked
The cited work used cell systems and purified binding proteins. It does not establish a safe or effective human anabolic intervention.
Abstract: numbered findings 2–4
- Selected primary-source passages checked with AI assistance. Scope cautions are editorial interpretations; this is not a complete literature review.
Check the identity statementSource checked
The experiment compared des-(1–3)-IGF-I with IGF-I and IGF-II. Keep these materials distinct when reading the results.
Abstract: numbered findings 2–4
- Selected primary-source passages checked with AI assistance. Scope cautions are editorial interpretations; this is not a complete literature review.
Inside the selected studies
Cell and binding-protein experiments
des-(1–3)-IGF-I
- Who or what was studied
- Chick embryo fibroblasts, L6 myoblasts and purified binding proteins
- Sample size
- Not established. Not established from the checked abstract; full methods require review.
- Compared with
- IGF-I and IGF-II; binding-protein comparisons
- Duration
- Not established. Not established from the checked abstract; full methods require review.
- Growth-factor activity and interactions with binding proteins.
- Selected study only; source mapping is not independent study-quality appraisal.
- This setting does not establish human treatment benefit.